menu-search
LEXISNEXIS_ICON4_SIGNINSign-in LEXISNEXIS_ICONS_SUPPORTHelp

International

View Life Sciences by content type:

News
Practice notes
Precedents
Q&As

Latest Life Sciences News

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

Life Sciences weekly highlights—22 July 2021

Life Sciences weekly highlights—22 July 2021

The following Life Sciences news provides comprehensive and up to date legal information on Life Sciences weekly highlights—22 July 2021

Brexit SI Bulletin—latest drafts and sifting committee reports, 16 July 2021

Brexit SI Bulletin—latest drafts and sifting committee reports, 16 July 2021

The following Life Sciences news provides comprehensive and up to date legal information on Brexit SI Bulletin—latest drafts and sifting committee reports, 16 July 2021

Life Sciences weekly highlights—15 July 2021

Life Sciences weekly highlights—15 July 2021

The following Life Sciences news provides comprehensive and up to date legal information on Life Sciences weekly highlights—15 July 2021

Featured Life Sciences content

Joint, several, and joint and several liability

Joint, several, and joint and several liability

Joint, several, and joint and several liabilityContractWhere a contract is made by two or more parties it may contain a promise or obligation made by...

Conditions precedent in commercial contracts

Conditions precedent in commercial contracts

Conditions precedent in commercial contractsThis Practice Note considers the meaning and use of conditions precedent in commercial arrangements. It...

Sub-licensing intellectual property rights

Sub-licensing intellectual property rights

An intellectual property (IP) owner may choose to license its IP to a third party. This can be an effective route to generating revenue while...

Co-operative and community benefit societies

Co-operative and community benefit societies

Co-operative and community benefit societiesWhat is a co-operative or community benefit society?A co-operative society or community benefit society...

Practice notes

Rome II—application and interpretation

Rome II—application and interpretationThis Practice Note is for use when determining applicable law in respect of events giving rise to damage, where...
Read More >
19th May
Q&As

Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and they sign as a director and in the name of that director?

Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and...
Read More >
19th May
Practice notes

Brexit—exiting the EU under Article 50 [Archived]

Brexit—exiting the EU under Article 50 [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note contains...
Read More >
Produced in partnership with Adam Cygan of University of Leicester 19th May
tag iconBrexit
Practice notes

Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)

Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)CASE HUB See further,...
Read More >
19th May
Q&As

Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered society grant a power of attorney to a third party to execute documents on its behalf?

Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered...
Read More >
19th May
Practice notes

Rome Convention—introduction and interpretation [Archived]

Rome Convention—introduction and interpretation [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.The UK is no longer...
Read More >
19th May
Precedents

Force majeure clause

Coronavirus (COVID-19): In addition to the below content on force majeure generally, see also: • Coronavirus (COVID-19)...
Read More >
19th May
tag iconCOVID-19 tag iconIn-house
Practice notes

Managing a breach of confidentiality or information security

Many companies and government bodies (such as HMRC) have been exposed to loss of confidential information and many other breaches of confidentiality...
Read More >
19th May
Practice notes

Introduction to retained EU law

Introduction to retained EU lawThis Practice Note provides an introduction to retained EU law. It provides an overview of the key definitions and...
Read More >
Produced in partnership with Dr. Kieran Laird of Gowling WLG 19th May
tag iconBrexit
Precedents

Counterparts clause

1 Counterparts—agreement 1.1 This agreement may be signed in any number of separate counterparts, each of which when...
Read More >
19th May
tag iconIn-house
Practice notes

Model ADR clauses

Model ADR clausesThis Practice Note considers model form alternative dispute resolution (ADR) clauses provided by a number of service providers,...
Read More >
19th May
Precedents

Execution clause—company—contract

Option 1—contract signed on behalf of a company, where the authorised signatory is an individual Signed by [insert name of...
Read More >
19th May
tag iconIn-house
Practice notes

Requirements of the company seal

Requirements of the company sealThis Practice Note provides practical guidance regarding the requirements of the company seal. Where a company has a...
Read More >
19th May
Practice notes

Brexit implementation period—enforcement [Archived]

Brexit implementation period—enforcement [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers...
Read More >
19th May
tag iconBrexit
Practice notes

Subcontracting

SubcontractingThis Practice Note examines the following legal and practical matters in relation to entering into a subcontract or when granting...
Read More >
19th May
Practice notes

Parallel imports

ScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that are placed on the...
Read More >
Produced in partnership with Taylor Wessing LLP 19th May

Most recent International content

Practice notes

Life sciences—Ireland—Q&A guide

Life sciences—Ireland—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to life sciences in Ireland published as part of the...
Read More >
25th Jul
Practice notes

Patents—Germany—Q&A guide

Patents—Germany—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to patents in Germany published as part of the Lexology Getting...
Read More >
25th Jul
Practice notes

Pharmaceutical antitrust—Romania—Q&A guide

Pharmaceutical antitrust—Romania—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical antitrust in Romania...
Read More >
25th Jul
Practice notes

Pharmaceutical antitrust—Spain—Q&A guide

Pharmaceutical antitrust—Spain—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical antitrust in Spain published...
Read More >
25th Jul
Practice notes

Pharma and medical device regulation—United Kingdom—Q&A guide

Pharma and medical device regulation—United Kingdom—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharma and medical...
Read More >
25th Jul
Practice notes

Pharma and medical device regulation—Italy—Q&A guide

Pharma and medical device regulation—Italy—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharma and medical device...
Read More >
25th Jul
Practice notes

Pharmaceutical antitrust—Portugal—Q&A guide

Pharmaceutical antitrust—Portugal—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical antitrust in Portugal...
Read More >
25th Jul
Practice notes

Pharma and medical device regulation—France—Q&A guide

Pharma and medical device regulation—France—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharma and medical device...
Read More >
25th Jul
Practice notes

Patents—Italy—Q&A guide

Patents—Italy—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to patents in Italy published as part of the Lexology Getting the...
Read More >
25th Jul
Practice notes

Pharmaceutical antitrust—Bulgaria—Q&A guide

Pharmaceutical antitrust—Bulgaria—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical antitrust in Bulgaria...
Read More >
25th Jul
Practice notes

Pharmaceutical antitrust—United Kingdom—Q&A guide

Pharmaceutical antitrust—United Kingdom—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical antitrust in United...
Read More >
25th Jul
Practice notes

Life sciences—Italy—Q&A guide

Life sciences—Italy—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to life sciences in Italy published as part of the Lexology...
Read More >
25th Jul
Practice notes

Life sciences—Germany—Q&A guide

Life sciences—Germany—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to life sciences in Germany published as part of the...
Read More >
25th Jul
Practice notes

Pharmaceutical trademarks—Iceland—Q&A guide

Pharmaceutical trademarks—Iceland—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Iceland...
Read More >
25th Jul
Practice notes

Life sciences—European Union—Q&A guide

Life sciences—European Union—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to life sciences in European Union published as...
Read More >
25th Jul
Practice notes

Pharmaceutical antitrust—Germany—Q&A guide

Pharmaceutical antitrust—Germany—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical antitrust in Germany...
Read More >
25th Jul
Practice notes

Life sciences—Netherlands—Q&A guide

Life sciences—Netherlands—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to life sciences in Netherlands published as part of...
Read More >
25th Jul
Practice notes

Pharma and medical device regulation—Austria—Q&A guide

Pharma and medical device regulation—Austria—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharma and medical device...
Read More >
25th Jul
Practice notes

Pharmaceutical trademarks—Germany—Q&A guide

Pharmaceutical trademarks—Germany—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Germany...
Read More >
25th Jul
Practice notes

Pharmaceutical trademarks—France—Q&A guide

Pharmaceutical trademarks—France—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in France...
Read More >
25th Jul

Popular documents

Insurable interest

Insurable interest

Insurable interestThis Practice Note considers insurable interest, including insurable interest in construction and liability insurance. It also considers insurable interest in subrogation, co-insurance and double insurance and the Insurable Interest Bill.What is insurable interest?‘Insurable

What is a public authority?

What is a public authority?

What is a public authority?There is no single, universal answer to the question whether a particular organisation is treated, in law, as a public authority.Rather, on one hand the courts have developed case law on which bodies are subject to administrative law through the judicial review procedure;

Highways, street works and statutory undertakers

Highways, street works and statutory undertakers

Highways, street works and statutory undertakersCoronavirus (COVID-19): This Practice Note contains guidance on matters that have temporarily been altered to assist in the management of the coronavirus (COVID-19) pandemic. For further information, see: Traffic Orders Procedure (Coronavirus)

Qualified one-way costs shifting (QOCS)

Qualified one-way costs shifting (QOCS)

Qualified one-way costs shifting (QOCS)What is QOCS?Qualified one-way costs shifting (QOCS) was introduced on 1 April 2013 as part of the Jackson costs reforms following the removal of a claimant’s right to recover additional liabilities from the defendant, ie success fees and after the event (ATE)